Failure of Conservative Treatment of Acute Diverticulitis with Extradigestive Air

P A Colas1,2, E Duchalais3, Q Duplay1,2

  • 1Department of Visceral Surgery, University Hospital of Angers, 4 Rue Larrey, 49933, Angers Cedex 9, France.

Abstract

Insights

Identifying risk factors for medical treatment failure in perforated diverticulitis without abscess or peritonitis (PDwAP) is crucial. Key indicators include significant pneumoperitoneum and fluid in the pouch of Douglas, guiding timely surgical intervention.

Area of Science:

  • Gastroenterology
  • Surgical Gastroenterology
  • Emergency Medicine

Background:

  • Medical management for perforated diverticulitis without abscess or peritonitis (PDwAP) has variable success rates (40-70%).
  • Identifying patients at risk for medical treatment failure is essential for improving outcomes.
  • This study aimed to pinpoint risk factors for medical treatment failure in PDwAP admissions.

Purpose of the Study:

  • To identify clinical, biological, and radiological risk factors associated with medical treatment failure in patients diagnosed with perforated diverticulitis without abscess or peritonitis.
  • To improve patient outcomes by enabling earlier surgical intervention when medical management is likely to fail.

Main Methods:

  • A multicenter retrospective observational study was conducted over seven years.
  • Included were consecutive patients admitted for PDwAP who did not undergo immediate surgical treatment (excluding Hinchey stage III/IV peritonitis).
  • Clinical, biological (e.g., C-reactive protein), and radiological data (e.g., pneumoperitoneum size, fluid location) were collected and compared between treatment failure and success groups.

Main Results:

  • Of 91 patients, 29 (31.9%) experienced medical treatment failure.
  • Higher median heart rate (approx. 100/min) and C-reactive protein (CRP) ≥150 mg/mL were observed in the failure group, though CRP was not significant in multivariate analysis.
  • Significant independent risk factors identified via multivariate analysis included pneumoperitoneum diameter >5 mm (OR 5.193) and peritoneal fluid in the pouch of Douglas (OR 4.103).

Conclusions:

  • Tachycardia and elevated CRP indicate sepsis severity, while significant pneumoperitoneum and fluid in the pouch of Douglas are key imaging indicators of potential medical treatment failure in PDwAP.
  • These identified risk factors necessitate close supervision and prompt consideration of surgical management to avoid delays.
  • Early recognition of these risk factors can optimize treatment strategies for PDwAP.

Related Concept Videos

Inflammatory Bowel Disease V: Surgical Management01:21

Inflammatory Bowel Disease V: Surgical Management

Surgical interventions for inflammatory bowel disease (IBD), which includes ulcerative colitis and Crohn's disease, are essential in managing symptoms and addressing complications. The selection of surgical procedures is contingent upon the specific conditions and complications that stem from these illnesses.
Here are some common surgical interventions for IBD:
785
Chronic Bowel Disorders: Introduction01:17

Chronic Bowel Disorders: Introduction

Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
867
Appendicitis-II: Diagnostic Studies and Management01:29

Appendicitis-II: Diagnostic Studies and Management

Diagnosing and managing appendicitis requires a structured and comprehensive approach that spans from initial assessment to postoperative care. Here is an overview of the process:
Diagnosing Appendicitis
It requires a multifaceted approach, starting with a detailed physical examination to pinpoint the location and nature of the pain and identify any associated symptoms. Laboratory tests play a crucial role. A complete Blood Count (CBC) typically reveals leukocytosis (an increased number of...
686
Esophageal Perforation-II: Clinical Manifestations and Management01:28

Esophageal Perforation-II: Clinical Manifestations and Management

Esophageal perforations manifest in various clinical forms, influenced by factors such as the perforation's cause and location (cervical, intrathoracic, or intra-abdominal), the extent of contamination, and potential injury to adjacent mediastinal structures. The timing between the perforation occurrence and treatment initiation also affects the clinical presentation.
Clinical Manifestations:
865
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy01:30

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy

Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
987
Inflammatory Bowel Disease II: Crohn's Disease01:30

Inflammatory Bowel Disease II: Crohn's Disease

Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
1.4K